Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Steatosis associates with insulin resistance and may even predict type 2 diabetes and cardiovascular complications. Because muscular insulin resistance relates to myocellular fat deposition and disturbed energy metabolism, we hypothesized that reduced hepatic ATP turnover (fATP) underlies insulin resistance and elevated hepatocellular lipid (HCL) contents. RESEARCH DESIGN AND METHODS: We measured hepatic fATP using 31P magnetic resonance spectroscopy in patients with type 2 diabetes and age- and body mass–matched controls. Peripheral (M and M/I) and hepatic (suppression of endogenous glucose production) insulin sensitivity were assessed with euglycemic-hyperinsulinemic clamps. RESULTS: Diabetic individuals had 29% and 28% lower peripheral and hepatic insulin sensitivity as well as 42% reduced fATP than controls. After adjusting for HCL, fATP correlated positively with peripheral and hepatic insulin sensitivity but negatively with waist circumference, BMI, and fasting plasma glucose. Multiple regression analysis identified waist circumference as an independent predictor of fATP and inorganic phosphate (PI) concentrations, explaining 65% (P = 0.001) and 56% (P = 0.003) of the variations. Hepatocellular PI primarily determined the alterations in fATP. CONCLUSIONS: In patients with type 2 diabetes, insulin resistance relates to perturbed hepatic energy metabolism, which is at least partly accounted for by fat depots.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In these studies, hepatic ATP production more strongly associated with hepatic than peripheral insulin sensitivity (130, 131).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [130]
In the citing paper
“However, as in muscle, 31 P-NMR measurements of hepatic mitochondrial ATP production reveal 23%-26% decreased ATP production in T2D individuals compared with age-and weightmatched nondiabetic controls (130, 131).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 3×
“We studied elderly volunteers who had a mean age of ~60 years, whichmight result in lower fATP analogous to data on myocellular fATP (8).”
BackgroundResultMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“In skeletal muscle, insulin resistance relates not only to elevated lipids but also to impaired rates of phosphorylation (flux throughATP synthesis, fATP), asmeasured by (31)P MRS in elderly (6) type 2 diabetic patients (7), their insulin-resistant firstdegree relatives (8), and nondiabetic individuals with elevated p…”
BackgroundNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664 · cited 2×
“In type 2 diabetes, insulin resistance develops as a result of inherited factors as well as from acquired factors that result in glucolipotoxicity due to chronic elevation of FFAs, triglycerides, or glucose (2,3).”
BackgroundDietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440 · cited 1×
“A short-term high-fat diet also leads to insulin resistance in liver, but not in skeletal muscle (17), whereas a hypocaloric diet decreases both hepatic fat content and insulin resistance within 48 h (18).”
BackgroundThe prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis
Rankinen, T., Kim, S.-Y., Pérusse, L., Després, J.-P., & Bouchard, C. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800929 · Cited by 414 · cited 1×
“Of note, waist circumference is the best anthropometric marker of abdominal visceral fat (19), which suggests, but does not prove, a role of visceral fat for hepatic energy metabolism.”
BackgroundMechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance
Roden, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0190 · Cited by 405
Self-citationMuscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243 · cited 5×
“A 20% dextrose infusion labeled with D-[6,6-(2)H2]glucose (2% enriched) according to the hot-glucose infusion protocol was periodically adjusted to maintain euglycemia (7).”
BackgroundMethodInfluentialSelf-citation
Cited by
Items 101–200 of 215
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake
Cooper, M., & Regnell, S. E. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12102 · Cited by 30
Mikolasevic, I., Domislovic, V, Turk Wensveen, T., Delija, B., Klapan, M., Juric, T., Lukic, A., Mijic, A., Skenderevic, N., Puz, P., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.08.005 · Cited by 28
Ding, Z., Xiao, Y., Wu, X., Zou, H., Yang, S., Shen, Y.-Y., Xu, J., Workman, H. C., Usborne, A. L., & Hua, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00410 · Cited by 29
Grattagliano, I., Ciaula, A. D., Baj, J., Molina‐Molina, E., Shanmugam, H., Garruti, G., Wang, D. Q. ‐., & Portincasa, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1433-4_12 · Cited by 30
Yan, H., Meng, Y., Li, X., Xiang, R., Hou, S., Wang, L., Wang, L., Yu, X., Xu, M., Chi, Y., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155372 · Cited by 32
KAHL, S., Straßburger, K., Pacini, G., Trinks, N., Pafili, K., Mastrototaro, L., Dewidar, B., Sarabhai, T., Trenkamp, S., Esposito, I., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.012 · Cited by 30
Self-citationNonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_18 · Cited by 33
Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
Szendroedi, J., Kaul, K., Kloock, L., Straßburger, K., Schmid, A. I., Chmelik, M., Kacerovsky, M., Kacerovsky-Bielesz, G., Prikoszovich, T., Brehm, A., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1359 · Cited by 27
Self-citationLi, J., Yan, H., Xiang, R., Yang, W., Ye, J., Yin, R., Yang, J., & Chi, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.918042 · Cited by 37
Queathem, E. D., Stagg, D. B., Nelson, A. B., Chaves, A., Crown, S. B., Fulghum, K., d’Avignon, D. A., Ryder, J. R., Bolan, P. J., Hayir, A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191021 · Cited by 27
Jakovljevic, N. K., Pavlović, K., Zujovic, T., Kravic‐Stevovic, T., Jotić, A., Marković, I., & Lalic, N. M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.10.001 · Cited by 29
Portillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 26
Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting
Yang, J., Zhang, L. J., Wang, F., Hong, T., & Liu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.007 · Cited by 25
Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice
López‐Soldado, I., Guinovart, J. J., & Durán, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100498 · Cited by 27
Pesta, D. H., Anadol, E., Sarabhai, T., den Kamp, Y. J. M. O., Gancheva, S., Trinks, N., Zaharia, O., Mastrototaro, L., Lyu, K., Habets, I., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr8849 · Cited by 27
Self-citationMolecular Basis of Irisin Regulating the Effects of Exercise on Insulin Resistance
Lin, J., Liu, X., Zhou, Y., Zhu, B., Wang, Y., Cui, W., Peng, Y., Wang, B., Chen, Z., & Zhao, R. (2022) · Applied Sciences · doi:10.3390/app12125837 · Cited by 27
Sarabhai, T., Mastrototaro, L., KAHL, S., Bönhof, G. J., Jonuscheit, M., Bobrov, P., Katsuyama, H., Guthoff, R., Wolkersdorfer, M. F., Herder, C., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05797-0 · Cited by 24
Self-citationPfleger, L., Gajdošík, M., Wolf, P. S., Smajis, S., Fellinger, P., Kuehne, A., Krumpolec, P., Trattnig, S., Winhofer, Y., Krebs, M., et al. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26225 · Cited by 22
Self-citationJiang, B., Lv, Q., Wan, W., Le, L., Xu, L., Hu, K., & Xiao, P. (2018) · Food & Function · doi:10.1039/c8fo00965a · Cited by 22
Rogers, C., Davis, B., Neufer, P. D., Murphy, M. P., Anderson, E. J., & Robidoux, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.012 · Cited by 25
Lundbom, J. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00399.2017 · Cited by 21
Wolf, P. S., Fellinger, P., Pfleger, L., Smajis, S., Beiglböck, H., Gajdošík, M., Anderwald, C. H., Trattnig, S., Luger, A., Winhofer, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39362-4 · Cited by 22
Self-citationIntracellular lipid accumulation and shift during diabetes progression
Wolf, P. S., Winhofer, Y., Anderwald, C. H., Krššák, M., & Krebs, M. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0292-y · Cited by 20
Self-citationInsulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 25
Self-citationDapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling
Kuang, J.-R., Zhang, Z., Leng, W., Lei, X., & Liang, Z. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.028 · Cited by 20
Surugihalli, C., Porter, T. E., Chan, A., Farley, L. S., Maguire, M., Zhang, C., Kattapuram, N., Muyyarikkandy, M. S., Liu, H., & Sunny, N. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-56715-1 · Cited by 26
Buehler, T., Kreis, R., & Boesch, C. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3242 · Cited by 20
Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases
Devesa, A., Delgado, V., Valkovič, L., Lima, J. A. C., Nagel, E. C., Ibáñez, B., & Raman, B. (2025) · Circulation Research · doi:10.1161/circresaha.125.325517 · Cited by 21
One‐dimensional image‐selected in vivo spectroscopy localized phosphorus saturation transfer at 7T
Valkovič, L., Bogner, W., Gajdošík, M., Považan, M., Kukurová, I. J., Krššák, M., Gruber, S., Frollo, I., Trattnig, S., & Chmelík, M. (2014) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25058 · Cited by 19
Self-citationKAHL, S., Nowotny, B., Piepel, S., Nowotny, P., Straßburger, K., Herder, C., Pacini, G., & Roden, M. (2014) · Diabetologia · doi:10.1007/s00125-014-3328-3 · Cited by 19
Self-citationHasenour, C. M., Kennedy, A. J., Bednarski, T., Trenary, I. A., Eudy, B. J., da Silva, R. P., Boyd, K. L., & Young, J. D. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000183 · Cited by 18
Thiagarajan, P., Bawden, S., & Aithal, G. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040632 · Cited by 19
Huang, Y., Hsu, S.-M., Shie, F., Shiao, Y., Chao, L.-J., Chen, H., Yao, H.-H., Chien, M. A., Lin, C., & Tsay, H.-J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0260966 · Cited by 19
Kanti, G., Anadol, E., Bobrov, P., Straßburger, K., KAHL, S., Zaharia, O., Sarabhai, T., Karusheva, Y., Burkart, V., Markgraf, D. F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa150 · Cited by 16
Self-citationSindrome metabólico y diabetes
Lahsen, M. R. (2014) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(14)70010-0 · Cited by 15
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 23
Self-citationMitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches
Jia, L., Wei, Z., Luoqian, J., Wang, X., & Huang, C. (2025) · MedComm – Future Medicine · doi:10.1002/mef2.70026 · Cited by 18
Impact of Cold Ischemia on Mitochondrial Function in Porcine Hearts and Blood Vessels
Wiedemann, D., Schachner, T., Bonaros, N. E., Dorn, M., Andreas, M., Kocher, A. A., & Kuznetsov, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122042 · Cited by 15
Liver function as an engineering system
Ashworth, W., Pérez-Galván, C., Davies, N. A., & Bogle, I. D. L. (2016) · AIChE Journal · doi:10.1002/aic.15292 · Cited by 14
La Estoria de España de Alfonso X: creación y evolución
Catalán, D. (1992) · Cited by 90
Early-life metabolic dysfunction impairs cognition and mitochondrial function in mice
Vilela, W. R., Bellozi, P. M. Q., Picolo, V. L., Cavadas, B. N., Marques, K. V. S., Pereira, L. T. G., Guirao, A. R. D. Y., Amato, A. A., Magalhães, K. G., Mortari, M. R., et al. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109352 · Cited by 12
Non‐alcoholic fatty liver disease in type 2 diabetes – A specific entity?
Schröder, B., KAHL, S., & Roden, M. (2021) · Liver International · doi:10.1111/liv.14846 · Cited by 13
Self-citationLópez‐Soldado, I., Guinovart, J. J., & Durán, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.969924 · Cited by 11
Grattagliano, I., Bonfrate, L., Lorusso, M. P., Castorani, L., de Bari, O., & Portincasa, P. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1875-1_12 · Cited by 10
Multiorgan, Multimodality Imaging in Cardiometabolic Disease
Kumar, V., Hsueh, W. A., & Raman, S. V. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.005447 · Cited by 11
Apoptosis: an underlying factor for accelerated periodontal disease associated with diabetes in rats
Tunalı, M., Ataoğlu, T., & Çelik, I. (2013) · Clinical Oral Investigations · doi:10.1007/s00784-013-1158-1 · Cited by 10
Hu, C.-Q., Hou, T., Xiang, R., Li, X., Li, J., Wang, T.-T., Liu, W., Hou, S., Wang, D., Zhao, Q., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00543-6 · Cited by 21
Takemoto, I., Kawagoe, N., Kijima, S., Sasaki, Y., Watanabe, T., & Urita, Y. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1276-y · Cited by 9
Vizioli, C., Jaime-Lara, R. B., Franks, A. T., Ortiz, R. V., & Joseph, P. V. (2020) · Biological Research For Nursing · doi:10.1177/1099800420942900 · Cited by 10
Alfadda, N. A., Aljuraiban, G. S., Awwad, H. M., Khaleel, M. S., Almaghamsi, A. M., Sherbeeni, S. M., Alqutub, A. N., Aldosary, A. S., & Alfadda, A. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.996004 · Cited by 9
Metabolic syndrome and the hepatorenal reflex
Wider, M. D. (2016) · Surgical Neurology International · doi:10.4103/2152-7806.190438 · Cited by 9
Jonuscheit, M., Wierichs, S., Rothe, M., Korzekwa, B., Mevenkamp, J., Bobrov, P., Kupriyanova, Y., Roden, M., & Schrauwen‐Hinderling, V. B. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5120 · Cited by 10
Self-citationWang, X., Dong, L., Gai, Q., Ai, W., Wu, Y. S., Xiao, W., Zhang, J., & An, W. (2020) · Hepatology Communications · doi:10.1002/hep4.1532 · Cited by 8
López‐Soldado, I., Guinovart, J. J., & Durán, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032574 · Cited by 8
The prerequisites for the development of type 2 diabetes or prediabetes in rats fed a high-fat diet
Portnychenko, A. G., Vasylenko, M., Алієв, Р. Б., Kozlovska, M. G., Zavhorodnii, M. O., Tsapenko, P. K., Rozova, K. V., & Портніченко, В. І. (2022) · Regulatory Mechanisms in Biosystems · doi:10.15421/022303 · Cited by 8
Jung, Y. S., Yun, K. U., Ryu, C. S., Oh, J. M., Kwak, H. C., Lee, J. Y., Park, S.-K., Kim, B. H., Oh, S. J., & Kim, S. K. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.04.014 · Cited by 8
Metabolic syndrome and the hepatorenal reflex
Wider, M. D. (2016) · Surgical Neurology International · doi:10.4103/2152-7806.194147 · Cited by 12
Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome
dos Santos, B. G., Brisnovali, N. F., & Goedeke, L. (2024) · Biochemical Journal · doi:10.1042/bcj20240005 · Cited by 8
Snogdal, L. S., Wod, M., Grarup, N., Vestmar, M. A., Sparsø, T., Jørgensen, T., Lauritzen, T., Beck‐Nielsen, H., Henriksen, J. E., Pedersen, O. B., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2377-0 · Cited by 9
Jeleník, T., Kodde, A., Pesta, D. H., Phielix, E., Oosting, A., Rohbeck, E., Dewidar, B., Mastrototaro, L., Trenkamp, S., Keijer, J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106193 · Cited by 9
Self-citationKAHL, S., Nowotny, B., Straßburger, K., Bierwagen, A., Klüppelholz, B., Hoffmann, B. H., Giani, G., Nowotny, P., Wallscheid, F., Hatziagelaki, E. E., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01773 · Cited by 6
Self-citationLee, J. I., Lee, H. M., Park, J., & Lee, Y. G. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70010 · Cited by 6
Kuga, G. K., Gaspar, R. C., Muñoz, V. R., Nakandakari, S. C. B. R., Breda, L., Sandoval, B. M., Caetano, F. H., Leme, J. A. C. D. A., Pauli, J. R., & Gomes, R. J. (2018) · Einstein (São Paulo) · doi:10.1590/s1679-45082018ao4353 · Cited by 7
Arroum, T., Pham, L., Raisanen, T. E., Morse, P. T., Wan, J., Bell, J., Lax, R., Saada, A., Hüttemann, M., & Weksler‐Zangen, S. (2023) · Antioxidants · doi:10.3390/antiox13010019 · Cited by 6
Hepatic Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) regulates metabolism in mice
Scott, C. H., Cha, K. M., Ngai, J., Jiang, C., Cheng, K., Stokes, R., Ho, K., George, J., Gonzalez, F. J., & Gunton, J. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186543 · Cited by 13
Bashir, A., Gropler, R. J., & Ackerman, J. J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143239 · Cited by 6
Molina‐Molina, E., Shanmugam, H., Palo, D. D., Grattagliano, I., & Portincasa, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1433-4_11 · Cited by 7
Imaging of MASLD: clinical standards and novel methods
Jonuscheit, M., & Schrauwen‐Hinderling, V. B. (2026) · Diabetologia · doi:10.1007/s00125-026-06799-y · Cited by 5
In vivo absolute quantification of hepatic γ‐ATP concentration in mice using 31P MRS at 11.7 T
Rothe, M., Wessel, C., Cames, S., Szendroedi, J., Burkart, V., Hwang, J., & Roden, M. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4422 · Cited by 4
Self-citationF1Fo adenosine triphosphate (ATP) synthase is a potential drug target in non-communicable diseases
Singh, V. M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08299-3 · Cited by 4
Inhibition of dynamin‐related protein 1‐filamin interaction improves systemic glucose metabolism
Kato, Y., Ariyoshi, K., Nohara, Y., Matsunaga, N., Shimauchi, T., Shindo, N., Nishimura, A., Mi, X., Kim, S. G., Ide, T., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16487 · Cited by 4
31P-MRS saturation transfer for assessing human hepatic ATP synthesis at clinical field strength
Jonuscheit, M., Korzekwa, B., Schär, M., Mevenkamp, J., Wierichs, S., Bobrov, P., Sarabhai, T., KAHL, S., Roden, M., & Schrauwen‐Hinderling, V. B. (2025) · European Radiology Experimental · doi:10.1186/s41747-025-00588-9 · Cited by 3
Self-citationZhao, T., Zhang, X., Xiang, Q., Liu, Y., Li, X., Gu, J., Zhang, W., Wang, Z., Li, Y., Lai, X., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090732 · Cited by 3
Kou, G., Luo, H., Huang, X., Bai, M., Cao, K., Ma, H., & Lv, X. (2024) · Advanced Chinese Medicine · doi:10.1002/acm4.1 · Cited by 3
Kappler, L., Kollipara, L., Lehmann, R., & Sickmann, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8367-0_9 · Cited by 5
Ponte, M. E., Prom, J. C., Newcomb, M. A., Jordan, A. B., Comfort, L. L., Hu, J., Puchalska, P., Koestler, D. C., Geisler, C. E., Hayes, M. R., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102167 · Cited by 2
Pareek, J., Mudgal, P., Sindhu, N., Tiwari, V., Tripathi, D. M., & Paliwal, S. (2025) · Cell and Tissue Research · doi:10.1007/s00441-025-03977-z · Cited by 2
Sun, Y., Sun, X. C., Liu, H., & Luo, F. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217412 · Cited by 2
Michorowska, S., Vogel, K. R., Jain, R., Clair, S. L. S., Simcox, J., & Parks, B. W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151059 · Cited by 3
Perry, C. G. R., & Wright, D. C. (2016) · The Journal of Physiology · doi:10.1113/jp272573 · Cited by 2
Role of Mitochondria in the Liver Metabolism in Obesity and Type 2 Diabetes
Katsuyama, H., Czeczor, J. K., & Roden, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00008-0 · Cited by 2
Self-citationSijens, P. E. (2015) · Wiley eBooks · doi:10.1002/9780470034590.emrstm1470 · Cited by 2
Bouazza, A., Fontaine, E. M., Leverve, X. M., & Koceir, E.-A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1839501 · Cited by 2
Ge, X., Ye, M., Fei, A., Zhang, Q., & Yuan, A. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106875 · Cited by 1
Berlanga, A., Guiu‐Jurado, E., Porras, J. A., Aragonès, G., & Auguet, T. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.03.003 · Cited by 4
Bcl10 and methylation of fatty acids: a future therapeutic target for Type 2 diabetes?
Jornayvaz, F. R. (2012) · Clinical Lipidology · doi:10.2217/clp.12.56 · Cited by 1
Qu, Y.-L., Deng, C.-H., Luo, Q., Shang, X., Wu, J., Shi, Y. Y., LanWang, & Han, Z. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/507517 · Cited by 1
Valkovič, L., Gajdošík, M., Chmelík, M., & Krššák, M. (2022) · Springer eBooks · doi:10.1007/978-3-642-35943-9_10094-1 · Cited by 1
Self-citationCauses and consequences of lipid overload in skeletal muscle, liver and heart
Bilet, L. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20150702lb
Rastmanesh, R., Marotta, F., Kantah, M., Nagpal, R., Lorenzetti, A., Takadanohara, H., Mashizume, H., Kobayashi, R., & Chui, D. H. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1271
Valkovič, L., Gajdošík, M., Traussnigg, S., Chmelík, M., Frollo, I., Trauner, M., Trattnig, S., & Krššák, M. (2013)
Self-citationAzizi, P. (2015) · TSpace (University of Toronto) · Cited by 1
Novel mechanisms of glucolipotoxic pancreatic beta cell death
Hanna, K. (2018) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) · Cited by 1
Cellular functional roles of celastrol on mitochondrial dysfunction-induced insulin resistance
Bakar, A., & Bakar, M. H. A. (2015)
Zheng, J., Chen, T., Guo, X., Ntambi, J. M., & Wu, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00014-2
Hypoglycemic Therapy in Chronic Hepatic Disease Literature Review
Imbeth‐Acosta, P. L., Pájaro-Galvis, N., Leal-Martínez, V., Rico-Fontalvo, J. E., Daza-Arnedo, R., Castañeda-López, O., Cardona-Blanco, M., Mercado-Anillo, K., Lucas-Daza, J., Pérez-Calvo, C., et al. (2020) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2020.1010013
Magnetic resonance imaging and spectroscopy: a noninvasive window into lipotoxicity
van Ewijk, P. A. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140701pe
Exercise and training in NAFLD and insulin resistance: psychological approach in humans
Brouwers, B. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160624bb
Moore, M. P. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/91011
Metadata
- Authors
- Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M.
- Affiliations
- Medical University of Vienna (AT)
- Deutsches Diabetes-Zentrum e.V. (DE)
- MR Center of Excellence, Medical University of Vienna, Vienna, Austria
- Corresponding author
- Roden, Michael
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 448-453
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024365
- OpenAlex
- W2171705653
- Cited by
- 212
- References
- 24
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 9 · 2022: 16 · 2021: 17 · 2020: 16 · 2019: 14 · 2018: 11 · 2017: 11 · 2016: 18 · 2015: 16 · 2014: 17 · 2013: 17 · 2012: 11
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- GlaxoSmithKline
- European Foundation for the Study of Diabetes
- Deutsche Forschungsgemeinschaft (SFB 575, Project 13)
- Oesterreichische Nationalbank (OENB 11459)
- European Association for the Study of Diabetes
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, hepatic insulin sensitivity, hepatic steatosis, inorganic phosphate, hepatic energy metabolism, waist circumference, hyperinsulinemic-euglycemic clamp, 31P NMR
- MeSH terms
- Adenosine Triphosphate, Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Energy Metabolism, Fatty Liver, Female, Humans, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Phosphorus Isotopes, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.